GlassScriptPhysician profile
James D Reeves
NPI 1962614933
$159,428.54
in general payments reported to CMS, 2019-2025
8 companies · $25K in 2025
The $25K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $34K · 2021: $3,874 · 2022: $1,315 · 2023: $26K · 2024: $14K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $14K · Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,407.00 |
| Travel and Lodging | $14,132.13 |
| Food and Beverage | $840.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $142,113.11 | 2019-2025 | Djo Surgical |
| Avanos Medical | $7,767.73 | 2019 | |
| Insight Medical Systems, INC. | $5,675.29 | 2023-2024 | Arvis |
| Smith+Nephew, INC. | $3,451.70 | 2019-2025 | |
| Stryker Corporation | $278.32 | 2019-2022 | |
| Heraeus Medical, LLC. | $83.80 | 2024-2025 | |
| Edwards Lifesciences Corporation | $37.23 | 2021 | |
| Djo, LLC | $21.36 | 2023 | Aircast, Donjoy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.